{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:19:48Z","timestamp":1773213588828,"version":"3.50.1"},"reference-count":197,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Our understanding of the mechanisms underlying multiple sclerosis (MS) has advanced substantially over recent decades, yet the primary drivers of disease onset and progression remain unclear. Immune dysregulation, particularly antibody-mediated processes and lymphocyte activation, is widely recognised as central to MS pathogenesis, and immune-targeted therapies have improved the management of relapsing disease. However, neither self-antigens nor self-antibodies have been definitively identified. This leaves open a fundamental question: does immune activation initiate MS, or does it arise in response to earlier pathological events? Most of our current knowledge relies on extrapolating findings from artificially induced models, which are mechanistically informative but may be limited in explaining spontaneous onset and responses to neurodegeneration in MS. Furthermore, the recent reclassification of conditions such as MOGAD and NMOSD, previously considered within the MS spectrum, has prompted renewed reflection on longstanding assumptions regarding MS aetiology. In this review, we refine the definition of autoimmune disease (AD) and apply a systematic, criterion-based evaluation of MS, complemented by direct comparison with well-established autoimmune conditions. Unlike previous reviews, which have largely addressed this question in conceptual terms, this paper explicitly examines whether MS fulfils the defining features of autoimmunity. By doing so, we highlight conceptual and evidentiary gaps that remain unresolved. Clarifying whether MS should be defined as autoimmune is not merely semantic, but has important implications for experimental modelling, biomarker discovery, and therapeutic development. By encouraging exploration beyond the conventional autoimmune framework, this review seeks to support a more integrative understanding of disease mechanisms.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1726369","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:29:43Z","timestamp":1773134983000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiple sclerosis and autoimmunity: a reappraisal of the evidence"],"prefix":"10.3389","volume":"17","author":[{"given":"Marie","family":"Amigo","sequence":"first","affiliation":[{"name":"School of Medicine, Faculty of Health, Western Sydney University","place":["Penrith, NSW, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monokesh K.","family":"Sen","sequence":"additional","affiliation":[{"name":"Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney","place":["Sydney, NSW, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Dunn","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Health, Western Sydney University","place":["Penrith, NSW, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Mahns","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Health, Western Sydney University","place":["Penrith, NSW, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/014107680509800616","article-title":"Multiple sclerosis: the history of a disease","volume":"98","author":"Orrell","year":"2005","journal-title":"J R Soc Med"},{"key":"B2","first-page":"554","article-title":"Histologie de la sclerose en plaques","volume":"41","author":"Charcot","year":"1868","journal-title":"Gazette Hopitaux"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The immune response in multiple sclerosis","volume":"17","author":"Rodr\u00edguez Mur\u00faa","year":"2022","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","article-title":"Blood\u2013brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies","volume":"23","author":"Zierfuss","year":"2024","journal-title":"Lancet Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612912","article-title":"Alterations of oligodendrocyte and myelin energy metabolism in multiple sclerosis","volume":"24","author":"L\u00f3pez-Muguruza","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2010.12.009","article-title":"The immunopathophysiology of multiple sclerosis","volume":"29","author":"Wu","year":"2011","journal-title":"Neurologic Clinics"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000728","article-title":"Diagnosis, differential diagnosis, and misdiagnosis of multiple sclerosis","volume":"25","author":"Solomon","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.106","article-title":"MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis\u2014clinical implementation in the diagnostic process","volume":"11","author":"Rovira","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.572186","article-title":"Revisiting the pathoetiology of multiple sclerosis: has the tail been wagging the mouse","volume":"11","author":"Sen","year":"2020","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.599717","article-title":"Pre-clinical and clinical implications of \u201cInside-out\u201d vs. \u201cOutside-in\u201d Paradigms in multiple sclerosis etiopathogenesis","volume":"14","author":"Titus","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3275","article-title":"Will the real multiple sclerosis please stand up","volume":"13","author":"Stys","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nri2190","article-title":"The origin and application of experimental autoimmune encephalomyelitis","volume":"7","author":"Baxter","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1721115115","article-title":"Biochemically altered myelin triggers autoimmune demyelination","volume":"115","author":"Caprariello","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00043","article-title":"CD8 T-cell recruitment into the central nervous system of cuprizone-fed mice: relevance to modeling the etiology of multiple sclerosis","volume":"14","author":"Almuslehi","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52001-2.00008-X","article-title":"The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment","volume":"122","author":"Robinson","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2004.06.006","article-title":"Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease","volume":"46","author":"Raivich","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pneurobio.2010.06.005","article-title":"Animal models of multiple sclerosis\u2014Potentials and limitations","volume":"92","author":"Mix","year":"2010","journal-title":"Prog Neurobiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3168","article-title":"Animal models of multiple sclerosis: the good, the bad and the bottom line","volume":"15","author":"Ransohoff","year":"2012","journal-title":"Nat Neurosci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.12703\/P5-20","article-title":"Pathoetiology of multiple sclerosis: are we barking up the wrong tree","volume":"5","author":"Stys","year":"2013","journal-title":"F1000Prime Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303291","article-title":"Interferon \u03b2 for secondary progressive multiple sclerosis: a systematic review","volume":"84","author":"La Mantia","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.18452\/404","article-title":"Gesammelte werke von robert koch","author":"Koch","year":"1912"},{"key":"B26","article-title":"The definition of autoimmune disease: are Koch\u2019s postulates applicable? - PubMed","volume":"60","author":"Damoiseaux","year":"2002","journal-title":"Netherlands J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/art.22029","article-title":"Fulfilling Koch\u2019s postulates of autoimmunity: Anti-NR2 antibodies in mice and men","volume":"54","author":"Pisetsky","year":"2006","journal-title":"Arthritis Rheumatism"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-006-0072-x","article-title":"Koch\u2019s postulates and infectious proteins","volume":"112","author":"Walker","year":"2006","journal-title":"Acta Neuropathol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases (Witebsky\u2019s postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunol Today"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/736384","article-title":"Spondyloarthropathies in autoimmune diseases and vice versa","volume":"2012","author":"P\u00e9rez-Fern\u00e1ndez","year":"2012","journal-title":"Autoimmune Dis"},{"key":"B31","first-page":"194","article-title":"Autoinmunidad y enfermedad autoinmune: el mosaico de la autoinmunidad","volume":"16","author":"Shoenfeld","year":"2005","journal-title":"Autoinmunidad y Enfermedad Autoinmune"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-022-03353-3","article-title":"Overlapping rheumatoid arthritis and antisynthetase syndrome with secondary Sj\u00f6gren\u2019s syndrome: a case report and review of the literature","volume":"16","author":"Weerasinghe","year":"2022","journal-title":"J Med Case Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514564490","article-title":"A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scler"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8340-8","article-title":"Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis","volume":"264","author":"Kosmidou","year":"2017","journal-title":"J Neurol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514521515","article-title":"Gender and autoimmune comorbidity in multiple sclerosis","volume":"20","author":"Magyari","year":"2014","journal-title":"Mult Scler"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/10.19.2025","article-title":"A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins","volume":"10","author":"Cucca","year":"2001","journal-title":"Hum Mol Genet"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137354","article-title":"Macrophages and HLA-class II alleles in multiple sclerosis: insights in therapeutic dynamics","volume":"25","author":"Prapas","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B38","article-title":"\u201cThe role of HLA in MS susceptibility and phenotype.,\u201d","volume-title":"Emerging and evolving topics in multiple sclerosis pathogenesis and treatments","author":"Greer","year":"2015"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4110\/in.2013.13.6.240","article-title":"Increased lymphocyte infiltration in rheumatoid arthritis is correlated with an increase in LTi-like cells in synovial fluid","volume":"13","author":"Koo","year":"2013","journal-title":"Immune Netw"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.09.008","article-title":"Antibodies as mediators of brain pathology","volume":"36","author":"Brimberg","year":"2015","journal-title":"Trends Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308689100","article-title":"Multiple sclerosis: Brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood","volume":"101","author":"Skulina","year":"2004","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1191\/1352458503ms917oa","article-title":"Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration","volume":"9","author":"B\u00f8","year":"2003","journal-title":"Mult Scler"},{"key":"B43","article-title":"\u201cImmunosuppression in multiple sclerosis and other neurologic disorders","volume-title":"Pharmacology of immunosuppression","author":"Thompson Tsirka","year":"2022"},{"key":"B44","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","author":"Montalban","year":"2017","journal-title":"N Engl J Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40259-020-00435-w","article-title":"Failed, interrupted, or inconclusive trials on immunomodulatory treatment strategies in multiple sclerosis: update 2015\u20132020","volume":"34","author":"Rolfes","year":"2020","journal-title":"BioDrugs"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: A review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am J Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0939-8","article-title":"Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis","volume":"26","author":"Alivernini","year":"2020","journal-title":"Nat Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1365-2567.2008.02881.x","article-title":"The T-cell pool is anergized in patients with multiple sclerosis in remission","volume":"126","author":"Fransson","year":"2009","journal-title":"Immunology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2011.08.019","article-title":"Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced na\u00efve\/memory Breg ratio during a relapse but not in remission","volume":"239","author":"Knippenberg","year":"2011","journal-title":"J Neuroimmunology"},{"key":"B51","doi-asserted-by":"crossref","unstructured":"Multiple sclerosis patients have reduced resting and increased activated CD4+CD25+FOXP3+T regulatory cells\n          \n          10476\n          \n            \n              Verma\n              ND\n            \n            \n              Lam\n              AD\n            \n            \n              Chiu\n              C\n            \n            \n              Tran\n              GT\n            \n            \n              Hall\n              BM\n            \n            \n              Hodgkinson\n              SJ\n            \n          \n          10.1038\/s41598-021-88448-5\n          34006899\n          Sci Rep\n          11\n          2021","DOI":"10.1038\/s41598-021-88448-5"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/cells13060508","article-title":"Recombinant acetylcholine receptor immunization induces a robust model of experimental autoimmune myasthenia gravis in mice","volume":"13","author":"Theissen","year":"2024","journal-title":"Cells"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br J Pharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028977","article-title":"Experimental autoimmune encephalomyelitis (EAE) as animal models of multiple sclerosis (MS)","volume":"8","author":"Glatigny","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20743","article-title":"Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis","volume":"58","author":"Sriram","year":"2005","journal-title":"Ann Neurol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2014.06.003","article-title":"EAE is not a useful model for demyelinating disease","volume":"3","author":"Behan","year":"2014","journal-title":"Mult Scler Relat Disord"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2007.09.025","article-title":"Anti-idiotypic response in mice expressing human autoantibodies","volume":"45","author":"Di Niro","year":"2008","journal-title":"Mol Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.150.4.1629","article-title":"Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies","volume":"150","author":"Zhou","year":"1993","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1359685","article-title":"Animal models for type 1 and type 2 diabetes: advantages and limitations","volume":"15","author":"Singh","year":"2024","journal-title":"Front Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002825","article-title":"Acute disseminated encephalomyelitis","volume":"87","author":"Pohl","year":"2016","journal-title":"Neurology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/15525","article-title":"A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor","volume":"23","author":"Madsen","year":"1999","journal-title":"Nat Genet"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.11.026","article-title":"Immunopathology of Japanese macaque encephalomyelitis is similar to multiple sclerosis","volume":"291","author":"Blair","year":"2016","journal-title":"J Neuroimmunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e3280be58d8","article-title":"Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis","volume":"20","author":"Wingerchuk","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/08820139.2018.1529040","article-title":"Thyroglobulin antibodies are associated with symptom burden in patients with hashimoto\u2019s thyroiditis: A cross-sectional study","volume":"48","author":"Bari\u0107","year":"2019","journal-title":"Immunol Invest"},{"key":"B65","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ana.21524","article-title":"Immunoglobulins and complement in postmortem multiple sclerosis tissue","volume":"65","author":"Barnett","year":"2009","journal-title":"Ann Neurol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.3.311","article-title":"Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis","volume":"56","author":"Karni","year":"1999","journal-title":"Arch Neurol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41467-022-28120-2","article-title":"Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto\u2019s thyroiditis","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlab083","article-title":"Multiple sclerosis: microglia, monocytes, and macrophage-mediated demyelination","volume":"80","author":"Prineas","year":"2021","journal-title":"J Neuropathol Exp Neurol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20016","article-title":"Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion","volume":"55","author":"Barnett","year":"2004","journal-title":"Ann Neurol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J Exp Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3893","article-title":"Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis","volume":"172","author":"Bielekova","year":"2004","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.8.5120","article-title":"Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis","volume":"172","author":"Zang","year":"2004","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.883287","article-title":"Perspectives of at-risk individuals on preventive intervention for rheumatoid arthritis: A mini review","volume":"13","author":"Falahee","year":"2022","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e1316","DOI":"10.1002\/cti2.1316","article-title":"Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"10","author":"Lopez","year":"2021","journal-title":"Clin Transl Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2008.02999.x","article-title":"Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP","volume":"128","author":"Hedegaard","year":"2009","journal-title":"Immunology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2011249117","article-title":"Autoantibodies against central nervous system antigens in a subset of B cell-dominant multiple sclerosis patients","volume":"117","author":"Kuerten","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.1212\/WNL.0000000000201465","article-title":"Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging","volume":"100","author":"Cortese","year":"2023","journal-title":"Neurology"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/287335a0","article-title":"Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains","volume":"287","author":"Mattson","year":"1980","journal-title":"Nature"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.8.5730","article-title":"Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment","volume":"181","author":"Vincent","year":"2008","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00726-021-03111-7","article-title":"Multiple sclerosis and myelin basic protein: insights into protein disorder and disease","volume":"54","author":"Martinsen","year":"2022","journal-title":"Amino Acids"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26014","article-title":"Axon-myelin unit blistering as early event in MS normal appearing white matter","volume":"89","author":"Luchicchi","year":"2021","journal-title":"Ann Neurol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.52015","article-title":"Micro-diffusely abnormal white matter: An early multiple sclerosis lesion phase with intensified myelin blistering","volume":"11","author":"Luchicchi","year":"2024","journal-title":"Ann Clin Trans Neurol"},{"key":"B83","first-page":"1","article-title":"Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura","volume":"38","author":"Harrington","year":"1951","journal-title":"J Lab Clin Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13788","article-title":"Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence","volume":"25","author":"Gilhus","year":"2018","journal-title":"Eur J Neurol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.06.085","article-title":"Neuromyelitis optica: Passive transfer to rats by human immunoglobulin","volume":"386","author":"Kinoshita","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.09.002","article-title":"Myelin oligodendrocyte glycoprotein-specific antibodies from multiple sclerosis patients exacerbate disease in a humanized mouse model","volume":"86","author":"Khare","year":"2018","journal-title":"J Autoimmun"},{"key":"B87","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jneuroim.2013.05.010","article-title":"Exacerbation of experimental autoimmune encephalomyelitis by passive transfer of IgG antibodies from a multiple sclerosis patient responsive to immunoadsorption","volume":"262","author":"Pedotti","year":"2013","journal-title":"J Neuroimmunology"},{"key":"B88","article-title":"The reaction of placental GRP78 protein with sera from women with multiple sclerosis","volume":"14","author":"Gharesi-Fard","year":"2017","journal-title":"Iran J Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jid.2021.07.187","article-title":"Autoantibodies present in hidradenitis suppurativa correlate with disease severity and promote the release of proinflammatory cytokines in macrophages","volume":"142","author":"Carmona-Rivera","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01891","article-title":"Correlation between anti-myelin proteolipid protein (PLP) antibodies and disease severity in multiple sclerosis patients with PLP response-permissive HLA types","volume":"11","author":"Greer","year":"2020","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1136\/jnnp.2005.086116","article-title":"Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis","volume":"77","author":"Perini","year":"2006","journal-title":"J Neurology Neurosurgery Psychiatry"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01871.x","article-title":"Intrathecal IgM-synthesis does not correlate with the risk of relapse in patients with a primary demyelinating event","volume":"14","author":"Schneider","year":"2007","journal-title":"Eur J Neurol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/art.20745","article-title":"Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus","volume":"52","author":"Blanco","year":"2005","journal-title":"Arthritis Rheumatism"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy069","article-title":"T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention","volume":"141","author":"van Langelaar","year":"2018","journal-title":"Brain"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(03)00048-1","article-title":"Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls","volume":"137","author":"Van der Aa","year":"2003","journal-title":"J Neuroimmunology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.5.1375","article-title":"Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects","volume":"51","author":"Reijonen","year":"2002","journal-title":"Diabetes"},{"key":"B97","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/08916930290005927","article-title":"Specific proliferation towards myelin antigens in patients with multiple sclerosis during a relapse","volume":"35","author":"S\u00e1ez-Torres","year":"2002","journal-title":"Autoimmunity"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(83)90250-2","article-title":"Isolation of myelin basic protein-reactive T-cell lines from normal human blood","volume":"81","author":"Burns","year":"1983","journal-title":"Cell Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41586-023-06916-6","article-title":"Autoreactive T cells target peripheral nerves in Guillain\u2013Barr\u00e9 syndrome","volume":"626","author":"S\u00faken\u00edkov\u00e1","year":"2024","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.835763","article-title":"Brain antigens stimulate proliferation of T lymphocytes with a pathogenic phenotype in multiple sclerosis patients","volume":"13","author":"Gottlieb","year":"2022","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0165-5728(99)00224-6","article-title":"An alkali-soluble factor present in normal brain tissue inhibits antigen-specific lymphocyte proliferation","volume":"103","author":"Lindsey","year":"2000","journal-title":"J Neuroimmunology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13075-022-02896-6","article-title":"Both T and B cells are indispensable for the development of a PBMC transfer-induced humanized mouse model for SSc","volume":"24","author":"Shu","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20080159","article-title":"IL-12\u2013 and IL-23\u2013modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition","volume":"205","author":"Kroenke","year":"2008","journal-title":"J Exp Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"RP88826","DOI":"10.7554\/eLife.88826","article-title":"Spontaneous human CD8 T cell and autoimmune encephalomyelitis-induced CD4\/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1*15-positive multiple sclerosis humanized immune system mice","volume":"12","author":"Papazian","year":"2024","journal-title":"eLife"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B106","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-60327-285-8","volume-title":"Diagnostic criteria in autoimmune diseases","author":"Shoenfeld","year":"2008"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/969657","article-title":"Is multiple sclerosis an autoimmune disease","volume":"2012","author":"Wootla","year":"2012","journal-title":"Autoimmune Dis"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103424","article-title":"Is fibromyalgia an autoimmune disorder","volume":"23","author":"Clauw","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103648","article-title":"Immunopathogenesis of systemic lupus erythematosus: An update","volume":"23","author":"Arnaud","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1426231","article-title":"New views on the complex interplay between degeneration and autoimmunity in multiple sclerosis","volume":"18","author":"Stys","year":"2024","journal-title":"Front Cell Neurosci"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.61.10.1610","article-title":"Multiple sclerosis is not an autoimmune disease","volume":"61","author":"Chaudhuri","year":"2004","journal-title":"Arch Neurol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100022393","article-title":"Multiple sclerosis: autoimmune disease or autoimmune reaction","volume":"37","author":"Stys","year":"2010","journal-title":"Can J Neurol Sci"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1370\/afm.983","article-title":"Defining comorbidity: implications for understanding health and health services","volume":"7","author":"Valderas","year":"2009","journal-title":"Ann Fam Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12111828","article-title":"Multiple sclerosis and autoimmune comorbidities","volume":"12","author":"Nociti","year":"2022","journal-title":"J Pers Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00321","article-title":"MHC class II polymorphisms, autoreactive\u2009T-cells, and autoimmunity","volume":"4","author":"Tsai","year":"2013","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","article-title":"HLA-DR15 molecules jointly shape an autoreactive T cell repertoire in multiple sclerosis","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3395","article-title":"Class II HLA interactions modulate genetic risk for multiple sclerosis","volume":"47","author":"Moutsianas","year":"2015","journal-title":"Nat Genet"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3176","article-title":"High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis","volume":"47","author":"Goyette","year":"2015","journal-title":"Nat Genet"},{"key":"B119","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13059-017-1207-1","article-title":"The MHC locus and genetic susceptibility to autoimmune and infectious diseases","volume":"18","author":"Matzaraki","year":"2017","journal-title":"Genome Biol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1186\/gm105","article-title":"Multiple sclerosis: major histocompatibility complexity and antigen presentation","volume":"1","author":"Ramagopalan","year":"2009","journal-title":"Genome Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00760","article-title":"B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers","volume":"11","author":"van Langelaar","year":"2020","journal-title":"Front Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis: mechanisms and immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"key":"B123","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00011-018-1185-0","article-title":"A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future","volume":"68","author":"Gholamzad","year":"2019","journal-title":"Inflammation Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000382130","article-title":"Multiple sclerosis relapses: epidemiology, outcomes and management","volume":"44","author":"Kalincik","year":"2015","journal-title":"A Systematic Review. Neuroepidemiology"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61137-0","article-title":"Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial","volume":"386","author":"Le Page","year":"2015","journal-title":"Lancet"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013444.pub2","article-title":"Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis","volume":"5","author":"Filippini","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103312","article-title":"Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders","volume":"22","author":"Konen","year":"2023","journal-title":"Autoimmun Rev"},{"key":"B128","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S1474-4422(14)70231-5","article-title":"Treatment of progressive multiple sclerosis: what works, what does not, and what is needed","volume":"14","author":"Feinstein","year":"2015","journal-title":"Lancet Neurol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09248-6","article-title":"Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis","volume":"266","author":"Turner","year":"2019","journal-title":"J Neurol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3275","article-title":"Will the real multiple sclerosis please stand up","volume":"13","author":"Stys","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2010.11.006","article-title":"EAE: imperfect but useful models of multiple sclerosis","volume":"17","author":"Hart","year":"2011","journal-title":"Trends Mol Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011242","article-title":"Effect of disease-modifying therapy on disability in relapsing-remitting multiple sclerosis over 15 years","volume":"96","author":"Kalincik","year":"2021","journal-title":"Neurology"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120227","article-title":"Immunology of relapse and remission in multiple sclerosis","volume":"32","author":"Steinman","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/JIR.S286426","article-title":"The role of regulatory B cells in health and diseases: A systemic review","volume":"14","author":"Chekol Abebe","year":"2021","journal-title":"J Inflammation Res"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/ijms17091398","article-title":"Regulatory cell populations in relapsing-remitting multiple sclerosis (RRMS) patients: effect of disease activity and treatment regimens","volume":"17","author":"Rodi","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15980","article-title":"Longitudinal associations between quality of diet and disability over 7.5\u2009years in an international sample of people with multiple sclerosis","volume":"30","author":"Simpson-Yap","year":"2023","journal-title":"Eur J Neurol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12955-022-02046-1","article-title":"Understanding lifestyle self-management regimens that improve the life quality of people living with multiple sclerosis: a systematic review and meta-analysis","volume":"20","author":"Wills","year":"2022","journal-title":"Health Qual Life Outcomes"},{"key":"B139","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.intimp.2018.05.018","article-title":"Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis","volume":"61","author":"Dolati","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3390\/nu15081945","article-title":"Clinical and imaging outcomes after vitamin D supplementation in patients with multiple sclerosis: A systematic review","volume":"15","author":"Langlois","year":"2023","journal-title":"Nutrients"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.03.022","article-title":"Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: Differential short-term changes on corticosteroids therapy","volume":"176","author":"Navarro","year":"2006","journal-title":"J Neuroimmunology"},{"key":"B142","doi-asserted-by":"publisher","first-page":"e50017","DOI":"10.7759\/cureus.50017","article-title":"Myasthenia gravis: A systematic review","volume":"15","author":"Mishra","year":"2023","journal-title":"Cureus"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.17.1.369","article-title":"Structural basis of T cell recognition","volume":"17","author":"Garcia","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.6026\/97320630018730","article-title":"Toward a fractalomic idiotype\/anti-idiotypic paradigm","volume":"18","author":"Chiappelli","year":"2022","journal-title":"Bioinformation"},{"key":"B145","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.it.2009.11.001","article-title":"The idiotype connection: linking infection and multiple sclerosis","volume":"31","author":"Holm\u00f8y","year":"2010","journal-title":"Trends Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxg105","article-title":"Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells","volume":"15","author":"Zang","year":"2003","journal-title":"Int Immunol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PloS Med"},{"key":"B148","doi-asserted-by":"publisher","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","year":"2019","journal-title":"Science"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2021.03.009","article-title":"A catalog of GWAS fine-mapping efforts in autoimmune disease","volume":"108","author":"Caliskan","year":"2021","journal-title":"Am J Hum Genet"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70041-9","article-title":"Multiple sclerosis genetics","volume":"13","author":"Sawcer","year":"2014","journal-title":"Lancet Neurol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cca.2015.01.034","article-title":"Genetic determinants of risk and progression in multiple sclerosis","volume":"449","author":"Didonna","year":"2015","journal-title":"Clin Chim Acta"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.cell.2018.09.049","article-title":"Low-frequency and rare-coding variation contributes to multiple sclerosis risk","volume":"175","year":"2018","journal-title":"Cell"},{"key":"B153","doi-asserted-by":"publisher","first-page":"291ra93","DOI":"10.1126\/scitranslmed.aaa9223","article-title":"Genetic variants associated with autoimmunity drive NF\u03baB signaling and responses to inflammatory stimuli","volume":"7","author":"Housley","year":"2015","journal-title":"Sci Transl Med"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.147036","article-title":"Overlapping genetic susceptibility of seven autoimmune diseases:SPU tests based on genome-wide association summary statistics","volume":"851","author":"Zhao","year":"2023","journal-title":"Gene"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1186\/gm305","article-title":"Emerging patterns of genetic overlap across autoimmune disorders","volume":"4","author":"Richard-Miceli","year":"2012","journal-title":"Genome Med"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12793","article-title":"Transcriptional network analysis of peripheral blood leukocyte subsets in multiple sclerosis identifies a pathogenic role for a cytotoxicity-associated gene network in myeloid cells","volume":"102","author":"Jordan","year":"2024","journal-title":"Immunol Cell Biol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/nature05133","article-title":"Functional epistasis on a common MHC haplotype associated with multiple sclerosis","volume":"443","author":"Gregersen","year":"2006","journal-title":"Nature"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1111\/jon.12868","article-title":"MRI characteristics of Japanese macaque encephalomyelitis: comparison to human diseases","volume":"31","author":"Tagge","year":"2021","journal-title":"J Neuroimaging"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncl.2023.07.001","article-title":"Multiple sclerosis diagnostic delay and misdiagnosis","volume":"42","author":"Kaisey","year":"2024","journal-title":"Neurologic Clinics"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2010.06.009","article-title":"The role of antibodies in multiple sclerosis","volume":"1812","author":"Weber","year":"2011","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029058","article-title":"Biomarkers in multiple sclerosis","volume":"9","author":"Paul","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1912839117","article-title":"Inflammation-related plasma and CSF biomarkers for multiple sclerosis","volume":"117","author":"Huang","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B163","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00401-013-1082-0","article-title":"Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons","volume":"125","author":"Singh","year":"2013","journal-title":"Acta Neuropathol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100473","article-title":"Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases","volume":"4","author":"Yasumizu","year":"2024","journal-title":"Cell Genomics"},{"key":"B165","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41598-018-36274-7","article-title":"Comprehensive analysis of TCR-\u03b2 Repertoire in patients with neurological immune-mediated disorders","volume":"9","author":"Alves Sousa A de","year":"2019","journal-title":"Sci Rep"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12677","article-title":"Autoantibody-defined risk for Type 1 diabetes mellitus in a general population of schoolchildren: results of the Karlsburg Type 1 Diabetes Risk Study after 18 years","volume":"32","author":"Till","year":"2015","journal-title":"Diabetic Med"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103236","article-title":"Autoimmune pre-disease","volume":"22","author":"Bieber","year":"2023","journal-title":"Autoimmun Rev"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1159396","article-title":"Editorial: autoimmune pre-disease","volume":"14","author":"Hundt","year":"2023","journal-title":"Front Immunol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1002\/rai2.12043","article-title":"Mechanism-driven strategies for prevention of rheumatoid arthritis","volume":"2","author":"Holers","year":"2022","journal-title":"Rheumatol Autoimmun"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.01.012","article-title":"Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments","volume":"174","author":"Khalil","year":"2006","journal-title":"J Neuroimmunology"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318228c0b1","article-title":"Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis","volume":"77","author":"Pr\u00f6bstel","year":"2011","journal-title":"Neurology"},{"key":"B172","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W","article-title":"The role of B cells and autoantibodies in multiple sclerosis","volume":"47","author":"Archelos","year":"2000","journal-title":"Ann Neurol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.07.008","article-title":"B cells and antibodies in progressive multiple sclerosis: Contribution to neurodegeneration and progression","volume":"15","author":"Fraussen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(82)90059-5","article-title":"Oligoclonal IgG in multiple sclerosis and subacute sclerosing panencephalitis brains","volume":"2","author":"Mattson","year":"1982","journal-title":"J Neuroimmunol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02938-3","article-title":"An autoantibody signature predictive for multiple sclerosis","volume":"30","author":"Zamecnik","year":"2024","journal-title":"Nat Med"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116242","article-title":"Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients","volume":"91","author":"Valli","year":"1993","journal-title":"J Clin Invest"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.12.13.1255","article-title":"Molecular mimicry and immune-mediated diseases","volume":"12","author":"Oldstone","year":"1998","journal-title":"FASEB J"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10425","article-title":"Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis","volume":"53","author":"Tejada-Simon","year":"2003","journal-title":"Ann Neurol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1304281","article-title":"Mimicking the brain: Epstein-Barr virus and foreign agents as drivers of neuroimmune attack in multiple sclerosis","volume":"14","author":"Thomas","year":"2023","journal-title":"Front Immunol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12268","article-title":"EBV & HHV6 reactivation is infrequent and not associated with MS clinical course","volume":"130","author":"Simpson","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"B184","doi-asserted-by":"publisher","first-page":"eady0210","DOI":"10.1126\/scitranslmed.ady0210","article-title":"Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in systemic lupus erythematosus","volume":"17","author":"Younis","year":"2025","journal-title":"Sci Transl Med"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-024-01167-9","article-title":"Epstein-Barr virus as a potentiator of autoimmune diseases","volume":"20","author":"Robinson","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51401","article-title":"Mechanistic underpinning of an inside\u2013out concept for autoimmunity in multiple sclerosis","volume":"8","author":"\u2018t Hart","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"e85393","DOI":"10.1371\/journal.pone.0085393","article-title":"Maternal neurofascin-specific autoantibodies bind to structures of the fetal nervous system during pregnancy, but have no long term effect on development in the rat","volume":"9","author":"Hochmeister","year":"2014","journal-title":"PloS One"},{"key":"B188","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13075-023-03116-5","article-title":"Anti-Jo-1 autoantibodies: biomarkers of severity and evolution of the disease in antisynthetase syndrome","volume":"25","author":"Arcani","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12925","article-title":"Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index","volume":"23","author":"de Bock","year":"2016","journal-title":"Eur J Neurol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00531","article-title":"Elevated levels of proinflammatory cytokines in cerebrospinal fluid of multiple sclerosis patients","volume":"8","author":"Khaibullin","year":"2017","journal-title":"Front Immunol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2727042","article-title":"Serum and cerebrospinal fluid cytokine biomarkers for diagnosis of multiple sclerosis","volume":"2020","author":"Martynova","year":"2020","journal-title":"Mediators Inflammation"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-9846-x","article-title":"Cytokine profile in patients with progressive multiple sclerosis and its association with disease progression and disability","volume":"54","author":"Kallaur","year":"2017","journal-title":"Mol Neurobiol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3897\/folmed.65.e86576","article-title":"Changes in serum cytokine profile and deficit severity in patients with relapsing-remitting multiple sclerosis","volume":"65","author":"Slavov","year":"2023","journal-title":"Folia Med"},{"key":"B194","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1084\/jem.192.3.393","article-title":"Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction","volume":"192","author":"Babbe","year":"2000","journal-title":"J Exp Med"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103092","article-title":"Citrullination of myelin basic protein induces a Th17-cell response in healthy individuals and enhances the presentation of MBP85\u201399 in patients with multiple sclerosis","volume":"139","author":"Mart\u00edn Monreal","year":"2023","journal-title":"J Autoimmun"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00540","article-title":"Brain citrullination patterns and T cell reactivity of cerebrospinal fluid-derived CD4+ T cells in multiple sclerosis","volume":"10","author":"Faigle","year":"2019","journal-title":"Front Immunol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"eabn1823","DOI":"10.1126\/sciadv.abn1823","article-title":"Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis","volume":"8","author":"Bronge","year":"2022","journal-title":"Sci Adv"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1726369\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:29:47Z","timestamp":1773134987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1726369\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":197,"alternative-id":["10.3389\/fimmu.2026.1726369"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1726369","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"article-number":"1726369"}}